One of the most recent techniques for the diagnosis of EP (early pregnancy) in cattle on the farm is B-mode ultrasonography. Under field conditions, acceptable results may be achieved with ultrasonography from days 25 to 30 post-AI. The reliability of the test greatly depends on the frequency of the transducer used, the skill of the examiner, the criterion used for a positive PD (pregnancy diagnosis) and the position of the uterus in the pelvic inlet. Pregnancy protein assays (PAG, PSPB) may provide an alternative method to ultrasonography for determining EP or LEM/EFM (late embryonic/early foetal mortality) in the cow. Although early pregnancy factor is the earliest specific indicator for fertilization, its detection is entirely dependend on the use of the RIT (rosette inhibition test), therefore its use in the field needs further inventions. Preventive pharmaceutical treatments with hCG (human chorionic gonadotropin), GnRH (gonadotropin realising hormone), PRID (progesterone-releasing intravaginal device) or CIDR (controlled internal drug release) inserts at different time periods at or post-AI may have some benefit in decreasing PL (pregnancy loss), however further examinations are warranted to determine how and when these treatments may influence PL in the field.
Introduction


The extent of PL in dairy cows can be estimated from the difference between FR (fertilisation rate) and subsequent CR (calving rate). It is generally accepted that FR in healthy dairy cattle is of the order of 85 to 90% [1] and the CR is presently around 33 to 41%. The CR has decreased from 66% since 1951, to about 50% until 1975, and further more until recently to about 33.1% in Spain [2] , 33 .4% in Israel [3] , 37% in Canada [4] or 41% in Japan [5] . Therefore 44% to 58% of pregnancies are lost during gestation. Most of the losses may occur between days 8 and 16 post-AI (early embryonic mortality: EEM) [1] . Further 5% to 10% losses may occur between days 16 and 42 (late embryonic mortality: LEM) and between days 42 to pregnancy is ruled out, giving a non-pregnant diagnosis. The confirmation of ultrasonographic diagnoses is usually based on palpation per rectum of the uterus at two to three months post-AI, or upon spontaneous return to oestrus after AI. A cow is also considered pregnant if an embryo proper with a beating heart is recognised at a final UE on days 50 to 60 post-AI. Cows diagnosed as non-pregnant by palpation per rectum or by ultrasonography between days 50 to 90 are usually designated as non-pregnant [7] [8] [9] .
Transrectal UE, using a 5.0 MHz linear-array or sector transducer, is a moderately accurate method for selecting pregnant and non-pregnant cattle from as early as days 25 to 26. Field studies reported that 2% to 5% of the calving animals were incorrectly diagnosed as non-pregnant, and 8.7% to 36% of the non-calving cows were incorrectly diagnosed as pregnant [10] [11] [12] . However, according to Badtram et al. [13] , the sensitivity and specificity of the ultrasound test between days 23 and 31 post-AI were only 68.8% and 71.7%, respectively. In a recent study, maximum sensitivity and negative predictive value were reached at day 26 in heifers and day 29 in cows [14] .
Transrectal UE, using a 7.5 MHz linear-array transducer, provides a method with an accuracy of more than 90% to select pregnant (sensitivity 90.4%) and non-pregnant cattle (specificity 96.0%) from day 29 or 30 onwards [15] . When the recognition of an embryo proper with a beating heart was used as the criterion for a positive ultrasound PD, significantly (P < 0.001) more false negative and less false positive ultrasound diagnoses were made, in comparison with recognition of allantoic fluid [15] .
Under field conditions, acceptable results may be achieved with ultrasonography (using 5 or 7.5 MHz transducers) from days 25 to 30 after AI [10-12, 15, 16] . The reliability of the test greatly depends on the frequency of the transducer used, the skill of the operator [13], the criterion used for a positive pregnancy diagnosis [15] and the position of the uterus in the pelvic inlet [17] . More incorrect non-pregnancy diagnoses were made in cows between days 24 to 38 in which the uterus was located far cranial to the pelvic inlet, in comparison with cows in which the uterus was located within or close to the pelvic inlet [17].
Conceptus Proteins (PSPB, PAG)
Trophoblastic mono-and binucleate cells from the early bovine conceptus synthesize substantial amounts of proteins. Among these, one has been described as bPSPB (bovine pregnancy specific protein B) which enters into the maternal circulation [18] . In addition, a bPSPB related protein, designated bPAG (bovine pregnancy associated glycoprotein) [19] or bPAG1
[20] has been described. Bovine PSPB [21] and bPAG1 [20] are inactive aspartic acid proteinases, and are identical in genetic nucleotide sequence [22] [23] [24] . The isolated preparations of bPSPB and bPAG1 may differ in carbohydrate and sialic acid content, which may explain the minor differences in profile and disappearance from maternal circulation after calving or EM [15, 25, 26] . Because both bPSPB and bPAG1 are found in the maternal circulation during pregnancy, these proteins are good indicators of the presence of a live embryo. Both bPSPB and bPAG1 have been detected in the serum of some pregnant cows as early as days 15 to 22 [21, 27] or day 22 post-AI [28] .
Due to delayed appearance of these proteins in the blood in some cows, the use of these proteins for PD provides more accurate results when used from Days 28 to 30 onwards [15, 16, 23, 29] . Both bPSPB and bPAG1 have been detected in peripheral circulation during the postpartum period 70 to 100 days after calving [27, 30] . In a recent study, 56.7% and 44.9% of the false positive diagnoses based on bPSPB and bPAG1 tests, respectively, originated from cows that were inseminated within 70 days after calving [15] . These findings indicate that the presence of bPSPB and bPAG1 in the plasma of cows during early stages of the postpartum period may limit their use under field conditions. If only these cows are selected for the protein tests which are inseminated after day 50 [31] or day 70 [32] [33] [34] , post calving interference with the residual bPSPB and bPAG1 in the peripheral circulation during the postpartum period can be minimal. A further limitation after LEM is that protein levels may remain above the threshold level, although the concentration of both proteins decreases steadily [35, 36] . This is probably related to the relatively long half-life (7-8 days for bPSPB and 3-4 days for bPAG1) in the maternal circulation after EM [35, 37] .
Early Pregnancy Factor (EPF)
The earliest specific indication for fertilization and the continuing presence of a viable conceptus is a serum constituent, which has been originally detected in mice [38] . This substance is known as EPF (early pregnancy factor) and has also been described in women [39] , sheep [40] , cattle [41] and pigs [42] .
The reported and extraordinary properties of EPF include:
 Early appearance (within hours) after mating or insemination [39] ;
 Rapid disappearance following induced death or removal of the embryos [43, 44] .
These factors suggest that EPF may be the most useful tool for investigating early embryonic survival or failure [44] [45] [46] . At present, the detection of EPF is entirely dependent on the use of the RIT (rosette inhibition test) which is a biological test therefore it is not practical. A new diagnostic test, the ECF (early conceptus factor) test, has been developed recently for the field [47, 48] however it cannot accurately identify conception within days or any time before Day 21 of gestation.
Diagnosis of Pregnancy Losses
One of the advantages of UEs is that PL can be recognised by the absence of a heartbeat, the detachment of the foetal membranes, the appearance of particles in the foetal fluids or the lack of the embryo proper [49, 50] . UEs have revealed that LEM may occur in up to 23% of pregnancies [12, 51] . PL (8%) diagnosed by ultrasonography in cows between days 26 and 58 post-AI occurred at approximately day 29 (n = 1), day 33 (n = 3), day 37 (n = 3), day 40 (n = 2), day 44 (n = 1) and day 56 (n = 1) post-AI, respectively. The exact day of occurrence of LEM/EFM could not be determined because UE was performed at intervals of 3-4 days [36] .
After diagnosing spontaneous cases of LEM by ultrasonography, both plasma bPSPB and bPAG1 levels began to decline in most cases, while the corpus luteum continued to produce progesterone [28, 36, 37] . This confirms the previous observations [35, 52] and demonstrates that lower progesterone concentrations are not the cause of conceptus death.
The potential clinical significance of diagnosing EM is that early ultrasonographic detection and prostaglandin treatment of cows with EM/FM may reduce the number of days before re-insemination [53] .
Prevention of Pregnancy Losses by Pharmacological Treatment
Progesterone (P4) is unequivocally required for supporting gestation [54] , pregnancy maintenance has been positively correlated to plasma concentrations of P4 on Week 5 of gestation [55] , and P4 concentrations influence secretory functions of trophoblasts and pituitary during the first trimester of gestation [56] . However, one of the consequences of high milk production is an increased metabolic rate linked to a greater dry matter intake. This process reduces plasma concentrations of steroid hormones such as P4 and oestradiol (E2), with obvious impacts not only on fertility but also on gestation [57, 58] . Thus, milk production can affect negatively plasma steroid hormone concentrations during oestrus cycles after calving and/or at the onset of the foetal period [59, 60] . Therefore, it seems reasonable to suppose that one of the causes of PL in high producing dairy cows could be the suboptimal concentrations of P4 and E2 [60, 61] , either due to the increased steroid hormone catabolism, the sub-luteal function, or both. Thus, strategies that induce the formation of an additional corpus luteum by using human chorionic gonadotropin (hCG), gonadotropin realising hormone (GnRH) or by enhancing the progesterone concentrations with gestagens [62, 63] may contribute to increase P4 concentrations in high producing dairy cows [6] .
Preventive Pharmaceutical Treatment at AI
Pharmaceutical treatment at AI aims to improve PR by prevention of delayed ovulation and supporting the early luteal function as well as prevention of precocious luteolysis. Due to delayed ovulation precocious maturation changes take place on the oocyte which will reduce its fertilization and developmental capacity. Namely poor embryonic development is associated with low interferon-τ production, failed inhibition of luteolysis and EEM [64, 65] . A meta-analysis of the published results dealing with the treatment of dairy cows with GnRH at the time of insemination clearly demonstrates that GnRH analogue at the first post partum AI, at the second service after calving and in repeat breeder cows may significantly increase PRs [66] . It is very important to remark that GnRH treatment at oestrus exposed to heat stress can also improve PRs [67, 68] .
In contrast, treatments of dairy cows at AI with hCG failed to stimulate conception rates under field conditions [69, 70] .
Preventive Pharmaceutical Treatment in the Early Luteal Phase Post-AI
Pharmaceutical treatment between days 4 and 7 post-AI aims to prevent EEM by inducing the formation of accessory corpora lutea, enhancing plasma progesterone concentrations and providing further LH support to the corpus luteum graviditatis [71] . Significant increase in PR was achieved when hCG was given at Day 5 [72, 73] or at day 7 [70, 74, 75] , while hCG significantly increased PR only in some herds when it was given between days 4 and 9 post-AI [76] . In a recent study [77] , hCG treatment on day 5 post-TAI could significantly increase PR only in heifers (49.7% vs. 39.5%). In contrast, other studies reported a non-significant increase in PR when cows were treated with hCG between days 4 to 6 post-AI (14%: [78] ; 0.6%: [79] ; 3.9%: [80] ; 0.7%: [81] ; 2.3% post-TAI: [82] ; 0%: [83] ). At the same time a non-significant decrease in PR was reported when cows were treated with hCG on day 5 post-AI (-2.7%: [84] ; -7.7%: [85] ) or post-TAI (-0.3% parity > 2: [77] ).
Similarly GnRH may also induce formations of accessory corpora lutea however due to shorter duration of LH exposure they may produce less progesterone during the subsequent luteal phase [81] . GnRH treatment at Day 5 post-TAI could improve PR only in non-cycling cows [86] while GnRH treatment between days 4 and 9 post-AI was not able to improve PR [76] . PRID (progesterone realising intravaginal devices) or CIDR (controlled internal drug realising) inserts have also been used with inconsistent results between days 4 to 9 [76] , or from day 5 [83, 86, 87] post-AI for 7 days. When, CIDR devices inserted into the vagina on day 4 and removed on day 18 post-AI had no positive effect on PR [88] . Similarly when PRID was used in repeat-breeder cows between days 5 to 19 post-AI, had no positive effect on PR, however when the animals were evaluated by parity and stage of lactation, PRID treatment significantly increased PR in the first and second parity late lactation cows [89] . At the same time PR at days 45 to 60 was also unaffected by the treatment of an injectable progesterone (200 mg) on days 5, 7, 9 and 11 post-AI [83] .
Preventive Pharmaceutical Treatment in Mid Luteal Phase Post-AI
Several reports describe the use of a single GnRH injection between days 11 and 14 post-AI to increase PR (0% to 23%) (meta-analysis: [90] ). The scientific rationale for this treatment is to enhance embryo survival rates by delaying the luteolytic mechanism [91] which sometimes occurs by failure in maternal recognition of pregnancy. Some studies reported significant improvements of 10 to 12% in PRs [92] [93] [94] while others did not [95] [96] [97] . According to a recent study [98] , treatment with GnRH at AI and 12 days later increased the PR in high yielding dairy cows during warm season.
The CIDR inserts increased embryo survival between days 29 and 57 post-TAI when treatment for 7 days starting on Day 13 post-TAI was performed [99] . Similarly, PRID also improved PR when used from Day 10 post-AI for 7 days [87] .
Preventive Pharmaceutical Treatment after Early Pregnancy Diagnosis around Day 30 post-AI
Pregnant cows were supplemented with a PRID between days 36 and 42 post-AI for 28 days. Based on the odds ratio, the risk of PL was 2.4 times higher in non-treated cows than in treated ones: 12% (66/549) vs. 5.3% (29/549) of losses, respectively [100] . In a more recent study where treatment was started on day 28 of gestation, results were very similar: 16% (16/97) vs. 6% (6/102) losses for non-treated and treated cows, respectively [101] . These results support the hypothesis that sub-optimal progesterone concentrations in high producing dairy cows may compromise conceptus development. Under these conditions, intra-vaginal progesterone supplementation has the potential to reduce the incidence of PL during LE/EF period.
According to a recent study in herds with a high incidence of EFM of a non-infectious nature at PD (days [28] [29] [30] [31] [32] [33] [34] , treatment at the time of PD with progesterone in cows with one corpus luteum and with GnRH in cows with two or more corpora lutea should offer considerable benefits [102] . 
